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Previewspromise to be of use as an adjuvant for
several immunotherapeutic applications.
The use of lentiviral particles as carriers
for the in vivo delivery of cGAMP might
be an advantage in this setting.REFERENCES
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Intracellular nucleotide-binding leucine-rich repeat (NLR) receptors play central roles in human and plant
innate immunity. In this issue of Cell Host & Microbe, Wang et al. (2015) show that a single plant NLR can
detect diverse pathogen effectors by partneringwith different scaffolding proteins, which can each recognize
distinct effector targets.To detect the presence of pathogens, the
innate immune systems of plants and an-
imals both rely on a combination of cell
surface receptors and intracellular recep-
tors. Although their immune systems are
thought to have evolved independently,
the intracellular receptors of plants and
mammals share similar structural do-
mains in that most all of them contain a
nucleotide-binding domain and leucine-
rich repeats (NLR). In plants, NLR recep-
tors are noted for their specificity, with
most NLRs appearing to detect only a sin-
gle pathogen protein. How this specificity
is achieved at amolecular level has been a
topic of intense study since the first plant
NLR was described in 1994 (Whitham
et al., 1994). Research in the ensuing
two decades has revealed that different
NLR proteins have evolved different
recognition mechanisms, with some
NLRs detecting pathogen proteins via
direct binding, while others detect patho-
gens indirectly by detecting modifications
to other host proteins induced by the
pathogen (DeYoung and Innes, 2006).The indirect recognition mechanism
most typically involves formation of a
pre-activation complex between an NLR
protein and a second host protein that is
directly targeted by a pathogen effector
(DeYoung and Innes, 2006). Modification
of the effector target is then thought to
trigger a conformational change in the
NLR protein that enables nucleotide ex-
change and adoption of an activated
state (Takken and Goverse, 2012). This
type of indirect recognition mechanism
offers several advantages over a direct
recognition mechanism from the plant’s
perspective. First, to escape detection,
the pathogen would have to eliminate
the activity of the detected effector, which
presumably would decrease its virulence.
With a direct recognition mechanism, in
contrast, detection can potentially be
evaded by simply mutating a surface
residue involved in NLR binding, which
would likely not affect effector function.
A second advantage of the indirect re-
cognition system is that it enables detec-
tion of multiple different effectors ifthey cause similar modifications to the
same effector target. As an example, the
Arabidopsis RPM1 NLR protein detects
modification of RPM1 INTERACTING
PROTEIN 4 (RIN4) induced by two
sequence unrelated effector proteins,
AvrB and AvrRpm1 (Liu et al., 2011). This
ability to detectmultiple different effectors
with a single NLR is likely critical given
that plants lack an adaptive immune sys-
tem. With such a system, a single NLR
can mediate recognition of not only
diverse effectors, but also effectors from
diverse pathogens.
In this issue, Wang et al. (2015) take
the concept of indirect recognition a
step further. They show that the ZAR1
NLR protein of Arabidopsis can detect
different bacterial effector proteins via a
combinatorial system that enables ZAR1
to indirectly associate with different
effector targets (Figure 1). ZAR1 was orig-
inally identified as an NLR protein
required for recognition of the effector
protein HopZ1a fromPseudomonas syrin-
gae (Lewis et al., 2010). HopZ1a belongseptember 9, 2015 ª2015 Elsevier Inc. 265
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Figure 1. Multiple Options for Activating the ZAR1 NLR Protein
ZAR1 can form different pre-activation complexes with multiple members of the RLCK XII family of pseudokinases. In the top panel, the pre-activation
complex contains the ZED1 pseudokinase. ZAR1 is activated by acetylation of ZED1 by the effector HopZ1a from P. syringae. In the middle panel, ZAR1 forms
a pre-activation complex with the RKS1 pseudokinase. ZAR1 is activated by binding to PBL2 only after PBL2 is uridylylated by the effector AvrAC from
X. campestris. In the bottom panel, ZAR1 forms a pre-activation complex with at least three other members of the RLCK XII family. These RLCKs may function
as adaptors for yet-to-be identified effector targets or could possibly be modified directly, similar to ZED1.
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effectors and possesses protein acetyl-
transferase activity, which is required for
activation of ZAR1. Recognition of
HopZ1a by ZAR1 requires a second host
protein, which was named ZED1 for
HopZ-ETI DEFICIENT (Lewis et al.,
2013). ZED1 is a pseudokinase belonging
to family XII of the receptor-like cyto-
plasmic kinase (RLCK) superfamily and
was shown to bind to ZAR1 in a pre-acti-
vation complex. HopZ1a acetylates
ZED1, consistent with ZAR1 employing a
standard indirect recognition mechanism
in which modification of its ‘‘guardee’’
(ZED1) by a pathogen effector triggers
activation. The new results from Wang
et al. (2015), however, have enriched this
picture considerably.
In Wang et al. (2015)’s study, they
were investigating the genetic require-
ments for recognition of an effector
protein named AvrAC from the plant266 Cell Host & Microbe 18, September 9, 20pathogen Xanthomonas campestris pv.
campestris. AvrAC belongs to the FIC
family of type III secreted effectors and
has been shown to catalyze uridylylation
of its target proteins, specifically mem-
bers of RLCK family VII (Feng et al.,
2012), several of which have been shown
to function in signaling from cell surface
pathogen recognition receptors. When
AvrAC is transgenically overexpressed
in Arabidopsis seedlings, it arrests their
growth. Wang et al. (2015) screened for
mutants that continued to grow in the
presence of AvrAC expression. Surpris-
ingly, one of the genes identified as
required for AvrAC-triggered growth ar-
rest was ZAR1. This was surprising
because AvrAC and HopZ1 have entirely
different enzymatic activities and target
different families of kinases. Further-
more, ZED1 was not required for AvrAC
recognition. How then was ZAR1 recog-
nizing AvrAC?15 ª2015 Elsevier Inc.A partial answer to this question came
out of the samemutant screen. In addition
to mutations in ZAR1, Wang et al. (2015)
also isolated mutations in a second
gene, RKS1, which encodes a pseudoki-
nase closely related to ZED1. This result
suggested that ZAR1 can form com-
plexes with either ZED1 or RKS1 and
that it is the latter complex that mediates
AvrAC recognition. Molecular analyses
confirmed this hypothesis but deepened
the mystery as RKS1 proved not to be
substrate of AvrAC. In other words, even
though ZAR1 and RKS1 form a pre-
activation complex that detects AvrAC
enzymatic activity, neither are substrates
of AvrAC.
The answer to this puzzle comes from
prior work performed in the Noe¨l and
Zhou labs (co-authors on Wang et al.).
Using a yeast two-hybrid screen, the
Noe¨l lab had identified the RLCK protein
PBL2 as strongly interacting with AvrAC
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them to test whether PBL2 was required
for recognition of AvrAC, and it was
(Guy et al., 2013). Meanwhile, the Zhou
lab had previously shown that AvrAC
uridylated several RLCK proteins closely
related to PBL2 (PBL1, BIK1, and RIPK)
(Feng et al., 2012). Putting these observa-
tions together, the authors tested whether
PBL2 was a substrate of AvrAC, and
whether PBL2 interacted with either
ZAR1 or RKS1. The satisfying, and
exciting, answer was that PBL2 was
indeed a substrate and that PBL2 inter-
acted specifically with RKS1, but only
after it had been uridylylated by AvrAC
(Wang et al., 2015). Thus, ZAR1 appears
to be activated by sensing uridylylation
of PBL2, but this sensing appears to be
indirect, as it requires RKS1 as an adaptor
protein (Figure 1).
The finding that ZAR1 interacted with
at least two pseudokinase proteins,
RKS1 and ZED1, prompted Wang et al.
(2015) to investigate whether ZAR1 could
interact with other members of the ZED1/
RKS1 family (RLCK XII). Of the three
members they tested (ZRK3, ZRK6, and
ZRK15), all interacted with ZAR1, indi-
cating that ZAR1 can interact with multi-
ple RLCK XII proteins. Based on their
genetic data, though, RKS1 is the only
RLCK XII protein involved in AvrAC recog-
nition, and PBL2 is the only RLCK VII
protein required. Significantly, PBL2 and
RKS1 were not required for recognition
of HopZ1a; thus, other than ZAR1, there
is no overlap between AvrAC recognition
and HopZ1a recognition. Collectively,
these results suggest that each RLCK XII
family member may be mediating recog-
nition of a different pathogen effector via
interactions with a single NLR protein,
ZAR1. Furthermore, each RLCK XIIfamily member could potentially interact
with multiple effector targets, raising the
intriguing possibility that ZAR1 might
mediate recognition of dozens of different
effectors.
A second interesting point brought out
by the Wang et al. (2015) work is whether
PBL2 primarily functions as a ‘‘decoy’’ to
enable recognition of AvrAC, or whether
it has an important role in basal defense
systems independent of ZAR1. In favor
of the decoy hypothesis, mutation of
PBL2 had no effect on the virulence activ-
ity of AvrAC. Indeed, prior work has
shown that AvrAC contributes to virulence
primarily by modifying BIK1, a close rela-
tive of PBL2 (Feng et al., 2012). Thus,
from the pathogen’s perspective AvrAC
has no requirement to modify PBL2. In
this context, PBL2 would appear to be
functioning as a BIK1 decoy that can
then activate ZAR1 when it is modified.
However, other evidence suggests that
PBL2 may contribute to plant immunity
independent of ZAR1 and AvrAC. PBL2
retains kinase activity, yet this activity
is not required for activation of ZAR1.
Furthermore, pbl2 mutant Arabidopsis
are compromised in their responses to
pathogen molecules such as flg22 (a pep-
tide derived from bacterial flagellin) and
elf18 (a peptide derived from bacterial
elongation factor EfTu), and PBL2 inter-
acts strongly with the flg22 receptor
FLS2, and transcription of PBL2 is
induced by flg22 (Zhang et al., 2010).
Thus, PBL2 is likely being maintained by
evolution for both its function in cell-sur-
face-mediated immunity, and its function
in effector-triggered immunity, and should
not be considered purely a decoy.
Future work should reveal whether
PBL2 and ZED1 are themselves targeted
by multiple effectors, similar to RIN4,Cell Host & Microbe 18, Sand whether other RLCK XII family mem-
bers function as effector target adaptors
for ZAR1. If so, the repertoire of effectors
recognized by ZAR1 could be impressive
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